Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids

Aminoff, D. (1961) · Biochemical Journal · doi:10.1042/bj0810384 · Cited by 1,898

Application of a Microtechnique to Viral Serological Investigations

Sever, J. L. (1962) · The Journal of Immunology · doi:10.4049/jimmunol.88.3.320 · Cited by 1,615

Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein

Scheid, A., Caliguiri, L. A., Compans, R. W., & Choppin, P. W. (1972) · Virology · doi:10.1016/0042-6822(72)90418-7 · Cited by 325

Isolation and Purification of the Envelope Proteins of Newcastle Disease Virus

Scheid, A., & Choppin, P. W. (1973) · Journal of Virology · doi:10.1128/jvi.11.2.263-271.1973 · Cited by 293

Über 2-Desoxy-2.3-dehydro-sialinsäuren, II. Kompetitive Hemmung derVibrio-cholerae-Neuraminidase durch 2-Desoxy-2.3-dehyro-N-acyl-neuraminsäuren

Meindl, P., & Tuppy, H. (1969) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1969.350.2.1088 · Cited by 113

�ber 2-Deoxy-2,3-dehydro-sialins�uren, 1. Mitt.: Synthese und Eigenschaften von 2-Deoxy-2,3-dehydro-N-acylneuramins�uren und deren Methylestern

Meindl, P., & Tuppy, H. (1969) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/bf00903465 · Cited by 98

THE INHIBITION OF NEURAMINIDASE AND ANTIVIRAL ACTION

EDMOND, J. D., JOHNSTON, R. G., Kidd, D. A. A., Rylance, H. J., & Sommerville, R. G. (1966) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1966.tb01673.x · Cited by 62

Competitive inhibition of Vibrio cholerae neuraminic acids

Meindl, P. (1969) · Medical Entomology and Zoology · Cited by 61

Neuraminidase inhibition and viral chemotherapy

Haskell, T. H., Peterson, F. E., Watson, D., Plessas, N. R., & Culbertson, T. (1970) · Journal of Medicinal Chemistry · doi:10.1021/jm00298a027 · Cited by 51

Undisturbed release of influenza virus in the presence of univalent antineuraminidase antibodies

Becht, H., Hämmerling, U., & ROTT, R. (1971) · Virology · doi:10.1016/0042-6822(71)90035-3 · Cited by 51

Intramolecular Lactones of Sialic Acids

Rota, P., Rocca, P. L., Allevi, P., Pappone, C., & Anastasia, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218098 · Cited by 8

Synthesis of Sialic Acids and Sialic Acid Derivatives

Vliegenthart, J. F. G., & Kamerling, J. P. (1982) · Cell biology monographs · doi:10.1007/978-3-7091-8680-0_4 · Cited by 8

Distinguishing mammalian sialidases by inhibition kinetics with novel derivatives of 5-acetamido-2,6-anhydro-3,5-dideoxy-d-glycero-d-galacto-non-2-enonic acid, an unsaturated derivative of N-acetylneuraminic acid

Warner, T. G., Louie, A., Potier, M., & Ribeiro, A. A. (1991) · Carbohydrate Research · doi:10.1016/0008-6215(91)84030-i · Cited by 8

Mutation of the HANA protein of Sendai virus by passage in eggs

Itoh, M., Wang, X.-L., Suzuki, Y., & Homma, M. (1992) · Virology · doi:10.1016/0042-6822(92)91222-g · Cited by 8

Relationship between hemagglutinin and sialidase from Clostridium perfringens CN3870: chromatographic characterization of the biologically active proteins

Rood, J. I., & Wilkinson, R. G. (1976) · Journal of Bacteriology · doi:10.1128/jb.126.2.831-844.1976 · Cited by 8

2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors

Rocca, P. L., Rota, P., Piccoli, M., Cirillo, F., Ghiroldi, A., Franco, V., Allevi, P., & Anastasia, L. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115563 · Cited by 7

Novel pH-dependent regulation of human cytosolic sialidase 2 (NEU2) activities by siastatin B and structural prediction of NEU2/siastatin B complex

Rahman, M. M., Hirokawa, T., Tsuji, D., Tsukimoto, J., Hitaoka, S., Yoshida, T., Chuman, H., & Itoh, K. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.09.017 · Cited by 7

Case Studies in Drug Discovery

Blass, B. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411508-8.00013-x · Cited by 8

Er(OTf) 3 ‐Catalyzed Multicomponent Synthesis of 3,4‐Dihydro‐2 H ‐pyran via Hetero‐Diels‐Alder Reaction under Ambient Temperature

Ramesh, V., Shanmugam, S., & Devi, N. S. (2018) · ChemistrySelect · doi:10.1002/slct.201800270 · Cited by 7

Influenza A Virus Neuraminidase Inhibitors

Sriwilaijaroen, N., Vavricka, C. J., Kiyota, H., & Suzuki, Y. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2635-1_21 · Cited by 7

Non-Sialate Inhibitor of Influenza A/WSN/33 Neuraminidase

Wu, J. C., Peet, G. W., Coutts, S. J., Eckner, R. J., Griffin, J. A., & Farina, P. R. (1995) · Biochemistry · doi:10.1021/bi00021a029 · Cited by 7

Antiviral compounds in the pipeline to tackle H1N1 Influenza infection

Beigel, J. H. (2010) · Drugs of the Future · doi:10.1358/dof.2010.035.05.1487081 · Cited by 6

Pharmacologic background and clinical issue of anti-influenza drugs

Sato, M. (2024) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.24-00029 · Cited by 6

A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture

Barrere, B., Driguez, P., Maudrin, J., Doutheau, A., Aymard, M., & Quash, G. (1997) · Archives of Virology · doi:10.1007/s007050050166 · Cited by 5

Recent advances in sialidase inhibitors

Dowle, M. D., & Howes, P. D. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.11.1461 · Cited by 6

Got the Flu? Try a Designer Agent Derived from a Sugar

Unverzagt, C. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199316911 · Cited by 6

Anti-infectives Overview: The development of potential anti-influenza drugs

von Itzstein, M., Barry, J. G., & Chong, A. K. J. (1993) · Current Opinion on Therapeutic Patents · doi:10.1517/13543776.3.12.1755 · Cited by 6

Bei Grippe? … ein Designerwirkstoff auf Zuckerbasis

Unverzagt, C. (1993) · Angewandte Chemie · doi:10.1002/ange.19931051205 · Cited by 6

Bacterial diversity and metabolites: Exploring correlations with preservative properties in soybean pastes

Ren, F., Liu, M., & Tan, B. (2024) · Journal of Food Science · doi:10.1111/1750-3841.16982 · Cited by 5

A medicinal chemistry overview of direct-acting antivirals approved in 2013–2024 by US FDA

Nizi, M. G., Massari, S., Tabarrini, O., & Manfroni, G. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118105 · Cited by 8

Straightforward access to 2,3- and 3,4-unsaturated derivatives of N-glycolylneuraminic acid

Rota, P., Rocca, P. L., Franco, V., & Allevi, P. (2020) · Tetrahedron · doi:10.1016/j.tet.2020.131699 · Cited by 5

The Development of Carbohydrate-Based Influenza Virus Sialidase Inhibitors

Thomson, R. J., & von Itzstein, M. (2011) · Springer eBooks · doi:10.1007/978-3-7643-8927-7_5 · Cited by 5

A Substrate Mimetic Approach for Influenza Neuraminidase Inhibitors

Jeong, J.-W. (2004) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2004.25.10.1575 · Cited by 5

Monoclonal Antibodies as Probes for Neural Cell-Surface Glycoproteins

Goridis, C., Rougon, G. N., & Hirn, M. H. (1983) · Protides of the biological fluids · doi:10.1016/b978-0-08-029815-3.50120-3 · Cited by 5

Transformation of D ‐Serine to Highly Functionalized Cyclohexenecarboxylates in Study of Oseltamivir Synthesis

Lai, J., & Fang, J. (2012) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.201100637 · Cited by 4

The Development of Non-Carbohydrate-Based Influenza Virus Sialidase Inhibitors

Streicher, H., & Stanley, M. (2011) · Springer eBooks · doi:10.1007/978-3-7643-8927-7_6 · Cited by 4

Structure-Based Drug Design – The Use of Protein Structure in Drug Discovery

Lange, G. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00267-4 · Cited by 4

On the interaction of Trypanosoma cruzi neuraminidase and human lipoproteins

Prioli, R. P., Mejia, J. S., & Pereira, M. E. A. (1991) · European Journal of Epidemiology · doi:10.1007/bf00144998 · Cited by 4

Influenza virus changes cell-surface glycoproteins including major histocompatibility complex determinants on lymphocytes

Rotteveel, F. T. M., Neefjes, J., Ploegh, H. L., & Lucas, C. J. (1989) · Human Immunology · doi:10.1016/0198-8859(89)90039-6 · Cited by 4

Effects of neuraminidase on the phenotype of sindbis virus grown in fibroblasts obtained from patients with I-cell disease

Schlesinger, S., Sly, W. S., & Schulze, I. T. (1978) · Virology · doi:10.1016/0042-6822(78)90183-6 · Cited by 4

Effective inhibition of bacterial sialidases by phenolic acids and flavonoids

Gocheva, Y. G., Nikolova, M., Engıbarov, S., Lazarkevich, I., & Еneva, R. (2024) · International Journal of Secondary Metabolite · doi:10.21448/ijsm.1408367 · Cited by 3

Neuraminic acid — Structure, Chemistry, Biological Activity

Bianco, A., & Melchioni, C. (2002) · Studies in natural products chemistry · doi:10.1016/s1572-5995(02)80035-7 · Cited by 3

Design of Neuraminidase Inhibitors as Anti-Influenza Virus Agents

Jin, H., & Kim, C. U. (2003) · Advances in antiviral drug design · doi:10.1016/s1075-8593(03)04004-8 · Cited by 3

Inhibition of influenza A virus sialidase activity by sulfatide

Takahashi, T., Suzuki, T., Nishinaka, D., Murakami, M., Fujii, S., Hidari, K. I. P. J., Miyamoto, D., Li, Y., & Suzuki, Y. (2004) · International Congress Series · doi:10.1016/j.ics.2004.02.102 · Cited by 3

Neu-medullocytes, sialidase-positive B cells in the thymus, express autoimmune regulator (AIRE)

Kijimoto‐Ochiai, S., Kamimura, K., & Koda, T. (2019) · Scientific Reports · doi:10.1038/s41598-018-37225-y · Cited by 3

Inhibition of Sialidase

Taylor, N. R. (1998) · Methods and principles in medicinal chemistry · doi:10.1002/9783527612178.ch6 · Cited by 3

Possible role of sialic acid and endogenous neuraminidase in T-cell proliferation

Stancou, R., Dumitresco, S. M., & Robineaux, R. (1984) · Cell Biology International Reports · doi:10.1016/0309-1651(84)90044-4 · Cited by 3

Monoclonal antibodies raised against post-translational domains of the electroplax sodium channel

Ivey, S., Thornhill, W. B., & Levinson, S. R. (1991) · The Journal of Membrane Biology · doi:10.1007/bf01951555 · Cited by 3

Mycobiota of highly-preserved and easily-spoiled soybean pastes-what are their roles?

Ren, F., Liu, M., & Tan, B. (2025) · Food Microbiology · doi:10.1016/j.fm.2025.104876 · Cited by 2

Influenza Virus, Overview: Structures, Infection Mechanisms and Antivirals

Böhm, R., Haselhorst, T., & von Itzstein, M. (2014) · Springer eBooks · doi:10.1007/978-4-431-54836-2_148-1 · Cited by 2

Assay Systems: Testing of Antiviral Drugs in Cell Culture (In Vitro)

Eggers, H. J. (1988) · Springer eBooks · doi:10.1007/978-1-4684-7275-2_9 · Cited by 2

Influenza Virus Neuraminidase Inhibitors

Taylor, G. L., & Russell, R. J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00016-4 · Cited by 2

Crystallography and New Medicines: Examples from Influenza and Cell Death

Colman, P. M. (2014) · Australian Journal of Chemistry · doi:10.1071/ch14318 · Cited by 2

Neuraminidase enhances the initial steps of human T-cell leukemia virus type 1 replication

Tanaka, M., Sun, B., Tezuka, K., Fujisawa, J., Tanaka, Y., Hoshino, H., & Miwa, M. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.10.003 · Cited by 2

Metal‐binding Sites of N‐Acetylneuraminic Acid

Illi, S., Schulten, J., & Klüfers, P. (2012) · Zeitschrift für anorganische und allgemeine Chemie · doi:10.1002/zaac.201200415 · Cited by 2

Influenza Virus, Overview: Structures, Infection Mechanisms and Antivirals

Böhm, R., Haselhorst, T., & von Itzstein, M. (2014) · Springer eBooks · doi:10.1007/978-4-431-54841-6_148 · Cited by 2

Autoregulation of Cholinergic Neurotransmission in Airways Nerves

Watson, N. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7558-5_10 · Cited by 2

DESIGN AND SYNTHESIS OF CARBOHYDRATES AND CARBOHYDRATE MIMETICS AS ANTI‐INFLUENZA AGENTS

Pascolutti, M., & von Itzstein, M. (2016) · doi:10.1002/9781119006435.ch17 · Cited by 2

Anti-viral approaches against influenza viruses

Pleschka, S., Ludwig, S., Wolff, T., & Planz, O. (2006) · Springer eBooks · doi:10.1007/978-0-387-31047-3_5 · Cited by 1

Carboxylic-Acid-Based Neuraminidase Inhibitors

Epps, S. V. (2016) · Wiley-VCH eBooks · doi:10.1002/9783527693931.ch10 · Cited by 1

Case studies in drug discovery

Blass, B. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817214-8.00014-2 · Cited by 2

Human Parainfluenza Virus Infections

Beck, E. T., & Henrickson, K. J. (2014) · CRC Press eBooks · doi:10.1201/b16778-23 · Cited by 1

Influenza Virus Neuraminidase Inhibitors

Taylor, G. L. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50378-8 · Cited by 1

ZIKA VIRUS SERENE PROTEASE COMPLEX (NS2B-NS3) INHIBITION BY 2-AMINO-5-{[(1Z)-AMINO({[(Z)-BENZOYL]IMINO})METHYL]AMINO}-N-(5-AMINO-7-{[CARBAMOYL(PHENYL)METHYL]AMINO}-6-OXOHEPTYL)PENTANAMIDE, IN SILICO STUDIES

Singh, K. V., Merugu, R., & Solanki, J. S. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i5.17286 · Cited by 1

Resistance to Influenza Neuraminidase Inhibitors

Yen, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_32 · Cited by 1

Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza

Szollosi, D. E., & Bill, A. (2019) · Current Drug Targets · doi:10.2174/1389450120666190801115130 · Cited by 1

Neuraminidase / sialidase from influenza virus: its characteristics, nomenclature, measuring of activity, kinetics, inhibitors as therapeutic agents

del Campo, J. A. C. F. (2022) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2022.88.05.07 · Cited by 1

Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza

Thomson, R. J., & von Itzstein, M. (2011) · doi:10.1002/9780470929353.ch27 · Cited by 1

Über die Hemmung bakterieller Neuraminidasen durch verschiedene Anionen

Rau, W., & Müller, H. E. (1975) · Cellular and Molecular Life Sciences · doi:10.1007/bf01932430 · Cited by 1

Carbohydrate Mimetics in Drug Discovery

Kolb, H. C., Ernst, B., & Schwardt, O. (2005) · CRC Press eBooks · doi:10.1201/9781420027952.ch16 · Cited by 1

Development of Influenza Virus Sialidase Inhibitors

Pascolutti, M., Thomson, R. J., & von Itzstein, M. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677047.ch22 · Cited by 1

A Specific Inhibitor of Trypanosoma Cruzi Neuraminidase Found in Human Plasma

Prioli, R. P., Rosenberg, I., & Pereira, M. E. A. (1987) · Springer eBooks · doi:10.1007/978-3-642-72840-2_10 · Cited by 1

THE EFFECTS OF HYPOMORPHIC SIALIDASE EXPRESSION ON ATHEROSCLEROSIS

Yang, A. (2012) · MacSphere (McMaster University) · doi:10.71548/14532

Analogues of the Sialyl LewisxGroup and of the N‐Acetylneuraminic Acid in the Antiadhesion Therapy

Giannis, A. (2003) · Organic Synthesis Set · doi:10.1002/9783527620784.ch51b

Antiviral Drug Discovery

Meanwell, N. A., D’Andrea, S. V., Cianci, C., Dicker, I. B., Yeung, K., Belema, M., & Krystal, M. (2013) · Drug Discovery · doi:10.1002/9781118354483.ch11

Les inhibiteurs de neuraminidase face au risque de grippe aviaire

Gras‐Masse, H., & Willand, N. (2007) · Annales Pharmaceutiques Françaises · doi:10.1016/s0003-4509(07)90016-4

Synthesis and Structure-activity Relationships of Flavonoids Derived from Scutellaria baicalensis Georgi as Potent Anti-flu Agents against Tamiflu- resistant H1N1 Virus and H3N2 Virus

Lee, A., Liao, C.-W., Chang, W.-L., Yao, C., & Huang, W. (2012)

Molecular Modeling and Docking Studies of Neu5Ac2en analogues against Cholera toxin

John, J. B., & Sharmila, D. J. S. (2014)

CHARACTERIZATION OF INFLUENZA NUCLEOPROTEIN BODY DOMAIN AS ANTIVIRAL TARGET

Davis, A. M. (2016) · CSUSB ScholarWorks (California State University, San Bernardino)

Influenza

Snacken, R., & Wolff, T. (2003) · Informa Healthcare eBooks · doi:10.1201/9780203912348.pt1

A virtual screening procedure combining pharmacophore filtering and molecular docking with the LIE method

Tunca, G. (2012) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)

Natural Products as Treatments for and Leads to Active Compounds in Viral Diseases

Newman, D. J., & Cragg, G. M. L. (2011) · CRC Press eBooks · doi:10.1201/b11196-7

Fluorescence Imaging of Virus-infected Cells with a Sialidase Imaging Probe

Takahashi, T., Kurebayashi, Y., Otsubo, T., Ikeda, K., Minami, A., & Suzuki, T. (2016) · BUNSEKI KAGAKU · doi:10.2116/bunsekikagaku.65.689

New Approaches to Influenza ChemotherapyInhibitors

Calfee, D. P., & Hayden, F. G. (1998)

Design and synthesis of inhibitors for the human neuraminidase 3 enzyme

Zou, Y. (2011) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3qx3t

Influenza

Wolff, T., & Snacken, R. (2003) · CRC Press eBooks · doi:10.1201/b14823-3

Peer Review #2 of "Exploring the chemical space of influenza neuraminidase inhibitors (v0.1)"

(2016) · PeerJ · doi:10.7287/peerj.1958v0.1/reviews/2

Grippe

Manuguerra, J. (2004) · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses · doi:10.1016/s1166-8598(01)00070-9

Peer Review #1 of "Exploring the chemical space of influenza neuraminidase inhibitors (v0.1)"

(2016) · PeerJ · doi:10.7287/peerj.1958v0.1/reviews/1

Patent Evaluation Anti-infectives: Novel derivatives of ′-D-neuraminic acid for the treatment of viral infection

(1996) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.6.8.801

In memoriam Hans Tuppy (1924–2024)

Skern, T. (2024) · Archives of Virology · doi:10.1007/s00705-024-06059-7

Sialidase inhibitors as anti-influenza drugs

von Itzstein, M., & Dyason, J. C. (1999) · Advances in antiviral drug design · doi:10.1016/s1075-8593(99)80006-9

Drugs Targeting Influenza Virus Neuraminidase

Colman, P. M. (1998) · Springer eBooks · doi:10.1007/978-94-015-9028-0_8

Fluorescence Imaging of Viral Sialidase Activity Using a Fluorogenic Probe

Takahashi, T., Kurebayashi, Y., Otsubo, T., Ikeda, K., Minami, A., & Takeuchi, H. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-04153-1_23

Conception et évaluation d'inhibiteurs multivalents de sialidases bactériennes

Assailly, C. (2020) · doi:10.70675/242e680fz386ez4dadzafdfz0ba8c356f574

3-exomethylene sialic acid disaccharides as substrate-type sialidase inhibitors

Fukazawa, R., Oonuma, K., Maeda, R., Uezono, K., Kato, M., Koshino, H., Morita, M., Miyagi, T., Sodeoka, M., & Hirai, G. (2026) · Bulletin of the Chemical Society of Japan · doi:10.1093/bulcsj/uoag109

BindingDB Entry 714: Hydrophobic Benzoic Acids as Inhibitors of Influenza Neuraminidase.

BindingDB (2005) · UC San Diego · doi:10.7270/q2t72fn4

BindingDB Entry 681: Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity.

BindingDB (2005) · UC San Diego · doi:10.7270/q2gx48rz

BindingDB Entry 50006100: Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.

BindingDB (2020) · UC San Diego · doi:10.7270/q2377cp4

BindingDB Entry 50047665: A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.

BindingDB (2017) · UC San Diego · doi:10.7270/q2qn68qp

BindingDB Entry 50036848: BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.

BindingDB (2012) · UC San Diego · doi:10.7270/q2q81dsj

BindingDB Entry 642: Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase

BindingDB (2005) · UC San Diego · doi:10.7270/q2sf2td9

BindingDB Entry 50012749: 2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors.

BindingDB (2022) · UC San Diego · doi:10.7270/q2js9v42

BindingDB Entry 713: Hydrophobic Benzoic Acids as Inhibitors of Influenza Neuraminidase.

BindingDB (2005) · UC San Diego · doi:10.7270/q2z036cv

BindingDB Entry 50039182: Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.

BindingDB (2012) · UC San Diego · doi:10.7270/q2wd41kc

Einfluß von 2-Desoxy-2.3-dehydro-N-acetylneuraminsäure auf Myxovirus-Neuraminidasen und die Replikation von Influenza- und Newcastle Disease Virus / Influence of 2-Deoxy-2,3-dehydro-N-acetylneuraminic Acid on Myxovirus-neuraminidases and the Replication of Influenza- and Newcastle Disease Virus

Meindl, P., Bodo, G., Lindner, J., & Palese, P. (1971) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1971-0812 · Cited by 28

Acyl Amino Acid Derivatives as Novel Inhibitors of Influenza Neuraminidase

Kondoh, M., Furutani, T., Azuma, M., Ooshima, H., & Kato, J. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.870 · Cited by 13

Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)

Palese, P., Schulman, J. L., Bodo, G., & Meindl, P. (1974) · Virology · doi:10.1016/0042-6822(74)90458-9 · Cited by 113

Inhibition Studies onVibrio choleraeNeuraminidase

Brossmer, R., KEILICH, G., & Ziegler, D. (1977) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1977.358.1.391 · Cited by 17

Inhibition of Influenza Virus Replication by 2-Deoxy-2,3-Dehydro-N-Trifluoroacetylneuraminic Acid (Fana)

Schulman, J. L., & Palese, P. (1976) · Springer eBooks · doi:10.1007/978-1-4684-3129-2_32